Hypnotherapy for irritable bowel syndrome: An audit of one thousand adult patients

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 9, 2015, Pages 844-855

  Miller, V ^a   Carruthers, H R ^a   Morris, J ^a   Hasan, S S ^a   Archbold, S ^a   Whorwell, P J ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; DEFECATION HABIT; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GUT FOCUSED HYPNOTHERAPY; HUMAN; HYPNOSIS; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SEX RATIO; TREATMENT RESPONSE; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; DEPRESSION; FEMALE; HUMANS; HYPNOSIS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84926418182     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13145     Document Type: Article

References (62)

1. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014; 6: 71-80.
2. Wilson S, Roberts L, Roalfe A, Bridge P, Singh S. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 2004; 54: 495-502.
3. Hungin AP, Molloy-Bland M, Claes R, et al. Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care - A Rome Foundation Working Team Report. Aliment Pharmacol Ther 2014; 40: 1133-45.
4. Agrawal A, Whorwell PJ. Irritable bowel syndrome: diagnosis and management. BMJ 2006; 332: 280-3.
5. Atarodi SRS, Whorwell PJ. Faecal incontinence - the hidden scourge of irritable syndrome: a cross sectional study. BMJ Open Gastroenterology. 2014; 1: 1-6.
6. Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut 1986; 27: 37-40.
7. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20: 31-9.
8. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on healthrelated quality of life. Gastroenterology 2000; 119: 654-60.
9. Miller V, Hopkins L, Whorwell PJ. Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2004; 2: 1064-8.
10. Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014; 40: 1023-34.
11. Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep 2009; 11: 265-9.
12. Sethi S, Wadhwa V, LeClair J, et al. Inpatient discharge rates for the irritable bowel syndrome - an analysis of national trends in the United States from 1997 to 2010. Aliment Pharmacol Ther 2013; 38: 1338-46.
13. Nyrop KA, Palsson OS, Levy RL, et al. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther 2007; 26: 237-48.
14. Klein KB, Spiegel D. Modulation of gastric acid secretion by hypnosis. Gastroenterology 1989; 96: 1383-7.
15. Chiarioni G, Vantini I, De Iorio F, Benini L. Prokinetic effect of gutoriented hypnosis on gastric emptying. Aliment Pharmacol Ther 2006; 23: 1241-9.
16. Whorwell PJ, Houghton LA, Taylor EE, Maxton DG. Physiological effects of emotion: assessment via hypnosis. Lancet 1992; 340: 69-72.
17. Simren M, Ringstrom G, Bjornsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004; 66: 233-8.
18. Lea R, Houghton LA, Calvert EL, et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17: 635-42.
19. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997; 277: 968-71.
20. Miller V, Whorwell PJ. Hypnotherapy for functional gastrointestinal disorders: a review. Int J Clin Exp Hypn 2009; 57: 279-92.
21. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritablebowel syndrome. Lancet 1984; 2: 1232-4.
22. Harvey RF, Hinton RA, Gunary RM, Barry RE. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet 1989; 1: 424-5.
23. Galovski TE, Blanchard EB. The treatment of irritable bowel syndrome with hypnotherapy. Appl Psychophysiol Biofeedback 1998; 23: 219-32.
24. Vidakovic-Vukic M. Hypnotherapy in the treatment of irritable bowel syndrome: methods and results in Amsterdam. Scand J Gastroenterol Suppl 1999; 230: 49-51.
25. Forbes A, MacAuley S, Chiotakakou- Faliakou E. Hypnotherapy and therapeutic audiotape: effective in previously unsuccessfully treated irritable bowel syndrome? Int J Colorectal Dis 2000; 15: 328-34.
26. Palsson OS, Turner MJ, Johnson DA, Burnelt CK, Whitehead WE. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci 2002; 47: 2605-14.
27. Lindfors P, Unge P, Arvidsson P, et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials. Am J Gastroenterol 2012; 107: 276-85.
28. Moser G, Tragner S, Gajowniczek EE, et al. Long-term success of GUTdirected group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2013; 108: 602-9.
29. Lindfors P, Ljotsson B, Bjornsson E, Abrahamsson H, Simren M. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome. Neurogastroenterol Motil 2013; 25: 169-e86.
30. Wilson S, Maddison T, Roberts L, Greenfield S, Singh S. Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome. Aliment Pharmacol Ther 2006; 24: 769-80.
31. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome- the effect of hypnotherapy. Aliment Pharmacol Ther 1996; 10: 91-5.
32. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol 2002; 97: 954-61.
33. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003; 52: 1623-9.
34. Lindfors P, Unge P, Nyhlin H, et al. Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome. Scand J Gastroenterol 2012; 47: 414-20.
35. Vlieger AM, Menko-Frankenhuis C, Wolfkamp SC, Tromp E, Benninga MA. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology 2007; 133: 1430-6.
36. Rutten JM, Reitsma JB, Vlieger AM, Benninga MA. Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review. Arch Dis Child 2013; 98: 252-7.
37. Vlieger AM, Rutten JM, Govers AM, Frankenhuis C, Benninga MA. Longterm follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol 2012; 107: 627-31.
38. Whorwell PJ. Hypnotherapy for irritable bowel syndrome: the response of colonic and noncolonic symptoms. J Psychosom Res 2008; 64: 621-3.
39. Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004; 56: 271-8.
40. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl II): 43-7.
41. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402.
42. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
43. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res 1997; 42: 17-41.
44. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
45. Tellegen A, Atkinson G. Openness to absorbing and self-altering experiences ("absorption"), a trait related to hypnotic susceptibility. J Abnorm Psychol 1974; 83: 268-77.
46. FDA. Guidance for Industry: irritable bowel syndrome - clinical evaluation of drugs for treatment. Available at: http:// wwwfdagov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM205269pdf, 2012. Accessed July 2014
47. Maxton DG, Morris JA, Whorwell PJ. Ranking of symptoms by patients with the irritable bowel syndrome. BMJ 1989; 299: 1138.
48. Francis CY, Duffy JN, Whorwell PJ, Morris J. High prevalence of irritable bowel syndrome in patients attending urological outpatient departments. Dig Dis Sci 1997; 42: 404-7.
49. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987; 28: 423-5.
50. Carruthers HR, Morris J, Tarrier N, Whorwell PJ. Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndrome. BMC Complement Altern Med. 2010; 10: 75.
51. Whorwell PJ. Hypnotherapy: first line treatment for children with irritable bowel syndrome? Arch Dis Child 2013; 98: 243-4.
52. Carruthers HR, Miller V, Morris J, Evans R, Tarrier N, Whorwell PJ. Using art to help understand the imagery of irritable bowel syndrome and its response to hypnotherapy. Int J Clin Exp Hypn 2009; 57: 162-73.
53. Carruthers HR, Morris J, Tarrier N, Whorwell PJ. The Manchester Color Wheel: development of a novel way of identifying color choice and its validation in healthy, anxious and depressed individuals. BMC Med Res Methodol 2010; 10: 12.
54. Kennedy T, Jones R, Darnley S, Seed P, Wessely S, Chalder T. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ 2005; 331: 435.
55. Zijdenbos IL, deWit NJ, dervan Heijden GJ, Rubin G, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009; (1): CD006442.
56. Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006; 24: 21-37.
57. Miller V, Jones H, Whorwell PJ. Hypnotherapy for non-cardiac chest pain: long-term follow-up. Gut 2007; 56: 1643.
58. Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002; 123: 1778-85.
59. Maris RW. Suicide. Lancet. 2002; 360: 319-26.
60. Ford AC, Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther 2010; 32: 144-58.
61. Whorwell PJ. IBS: Hypnotherapy-a wasted resource? Nat Rev Gastroenterol Hepatol 2012; 9: 12-3.
62. Jones H, Cooper P, Miller V, Brooks N, Whorwell PJ. Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut 2006; 55 : 1403-8.